Morgan Stanley Cara Therapeutics, Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 105,863 shares of CARA stock, worth $27,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,863

Previous 293,148 63.89%

Holding current value

$27,524

Previous $216,000 55.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.52 - $1.05 $97,388 - $196,649	-187,285 Reduced 63.89%	105,863 $96,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.65 $16,729 - $46,006	-27,883 Reduced 8.69%	293,148 $216,000
Q3 2023 Nov 15, 2023	BUY	$1.67 - $3.33 $9,352 - $18,648	5,600 Added 1.78%	321,031 $539,000
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $182,786 - $319,069	-64,589 Reduced 17.0%	315,431 $892,000
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $556,457 - $1.4 Million	-113,795 Reduced 23.04%	380,020 $1.87 Million

Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $566,996 - $815,377	63,851 Added 14.85%	493,815 $5.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $1.16 Million - $1.77 Million	141,320 Added 48.96%	429,964 $4.02 Million
Q2 2022 Oct 27, 2022	BUY	$7.45 - $13.84 $345,523 - $641,885	46,379 Added 19.14%	288,644 $2.64 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $345,523 - $641,885	46,379 Added 19.14%	288,644 $2.64 Million
Q1 2022 Oct 27, 2022	SELL	$9.94 - $12.65 $461,007 - $586,694	-46,379 Reduced 16.07%	242,265 $2.94 Million
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $134,806 - $171,559	13,562 Added 5.93%	242,265 $2.94 Million
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $1.14 Million - $1.72 Million	-95,057 Reduced 29.36%	228,703 $2.79 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $3.74 Million - $5.2 Million	323,760 New	323,760 $5 Million

Others Institutions Holding CARA

# of Institutions

101

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account